Literature DB >> 11531945

The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.

N Van Damme1, F De Keyser, P Demetter, D Baeten, H Mielants, G Verbruggen, C Cuvelier, E M Veys, M De Vos.   

Abstract

T lymphocytes and their cytokines have an important role in the regulation of immune responses in the gut and in the pathogenesis of intestinal inflammation such as in Crohn's disease. The aim of this study was to analyse the Th1/Th2 cytokine profile (IFN-gamma, IL-2, IL-4 and IL-10) in intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) in Crohn's disease (CD) and ulcerative colitis (UC) in relation to healthy controls (C). Colonic and ileal biopsy specimens were obtained from controls (n = 13) and patients with CD (n = 32). Colonic biopsies were obtained from patients with UC (n = 11). Intracytoplasmic IFN-gamma, IL-2, IL-4 and IL-10 were determined by flow cytometry after PMA-ionomycin stimulation in IEL and LPL. In colonic LPL, a significant proportional decrease of IFN-gamma and IL-2 producing CD3+ cells was observed in patients with CD and UC compared to controls. In ileal LPL, a similar tendency was found although differences were not significant. In IEL no differences in cytokine profiles could be observed. Flow cytometric analysis of intracytoplasmic cytokines at single cell level showed a proportional decrease of IFN-gamma and IL-2 producing T cells in colonic lamina propria in patients with inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531945      PMCID: PMC1906156          DOI: 10.1046/j.1365-2249.2001.01638.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy.

Authors:  N Van Damme; M De Vos; D Baeten; P Demetter; H Mielants; G Verbruggen; C Cuvelier; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

2.  Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease.

Authors:  P Desreumaux; E Brandt; L Gambiez; D Emilie; K Geboes; O Klein; N Ectors; A Cortot; M Capron; J F Colombel
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

3.  Azathioprine, mycophenolate mofetil, and methotrexate specifically modulate cytokine production by T cells.

Authors:  K Hildner; E Märker-Hermann; J F Schlaak; C Becker; T Germann; E Schmitt; K H Meyer zum Büschenfelde; M F Neurath
Journal:  Ann N Y Acad Sci       Date:  1998-11-17       Impact factor: 5.691

4.  A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.

Authors:  S E Plevy; C J Landers; J Prehn; N M Carramanzana; R L Deem; D Shealy; S R Targan
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

Review 5.  Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

Authors:  L Van Parijs; A K Abbas
Journal:  Science       Date:  1998-04-10       Impact factor: 47.728

6.  Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.

Authors:  M Kjerrulf; D Grdic; L Ekman; K Schön; M Vajdy; N Y Lycke
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

7.  Regulation of CD4 and CD8 expression on mouse T cells. Active removal from the cell surface by two mechanisms.

Authors:  S J Anderson; C Coleclough
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

8.  Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.

Authors:  I J Fuss; M Neurath; M Boirivant; J S Klein; C de la Motte; S A Strong; C Fiocchi; W Strober
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

9.  The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.

Authors:  H Mielants; E M Veys; C Cuvelier; M De Vos; S Goemaere; L De Clercq; L Schatteman; L Gyselbrecht; D Elewaut
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

10.  Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis.

Authors:  Y Morita; M Yamamura; M Kawashima; S Harada; K Tsuji; K Shibuya; K Maruyama; H Makino
Journal:  Arthritis Rheum       Date:  1998-09
View more
  14 in total

1.  Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.

Authors:  I E A Hoffman; P Demetter; M Peeters; M De Vos; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

2.  Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease.

Authors:  Francisco León; Laura Sánchez; Cristina Camarero; Garbiñe Roy
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

3.  Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Galphai2-deficient mice.

Authors:  L Ohman; R Willén; O H Hultgren; E Hultgren Hörnquist
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

Review 4.  Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience.

Authors:  J Braun; J Sieper; M Breban; E Collantes-Estevez; J Davis; R Inman; H Marzo-Ortega; H Mielants
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

5.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 6.  Gut inflammation and spondyloarthropathies.

Authors:  Filip De Keyser; Dominique Baeten; Filip Van den Bosch; Martine De Vos; Claude Cuvelier; Herman Mielants; Eric Veys
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

Review 7.  Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.

Authors:  Filip De Keyser; Dominique Baeten; Filip Van den Bosch; Elli Kruithof; Gust Verbruggen; Herman Mielants; Eric Veys
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Gut inflammation in the spondyloarthropathies.

Authors:  Herman Mielants; Filip De Keyser; Dominique Baeten; Filip Van den Bosch
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

9.  Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.

Authors:  Shao-Ping Liu; Wei-Guo Dong; Dong-Fang Wu; He-Sheng Luo; Jie-Ping Yu
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Inflammatory bowel disease in rats: bacterial and chemical interaction.

Authors:  Inaya-Abdallah Hajj Hussein; Rania Tohme; Kassem Barada; Mostafa Hassan Mostafa; Jean-Noel Freund; Rosalyn A Jurjus; Walid Karam; Abdo Jurjus
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.